| 08.25 (Tuesday) |
The Platz Seminar Room |
P-0 |
10:00 - 12:00 |
K-Bio Innovation Modality & Tech Commercialization |
Korea Institute of Toxicology(KIT) |
|
| 10:00 - 10:20 |
K-Bio Modality & Tech Commercialization |
1004 VenturePartners |
Soyoung Park, CEO |
K / E |
| 10:25 - 10:40 |
Innovative ADC Technology |
Cyron Therapeutics |
Sangsoon Yoon, CEO |
K |
| 10:40 - 10:55 |
Innovative TPD Technology |
UPPthera |
Siwoo Choi, CEO |
K |
| 10:55 - 11:10 |
Innovative Radiopharmaceuticals |
VS PharmTech |
Hoyun Nam, Director |
K |
| 11:10 - 11:25 |
Next-Generation Quantum Drug Discovery Technologies |
Quantum Intelligence |
Keunsu Choi, Principal Researcher |
K |
| 11:25 - 11:55 |
Global Commercialization of K-Bio |
|
|
|
| P-1 |
12:50 - 14:20 |
2026 Regenerative Medicine Investment Strategy & IR Partnering Day |
Korean Fund for Regenerative Medicine (KFRM) |
|
| 13:00 - 13:15 |
Introduction about TIPS Program |
KBAA (Korea Business Angels Association) |
Ingyu Yoon, Team Manager |
K |
| 13:15 - 13:30 |
SCALEUP TIPS: Program and Key Cases |
Korea Venture Capital Assciation(KVCA) |
Changyeon Lee, Team Manager |
K |
| 13:30 - 14:20 |
IR |
|
|
|
| P-3 |
15:10 - 16:00 |
PSCI – Driving Responsible Pharmaceutical Supply Chains: Best Practices and Insights |
Boehringer-Ingelheim Korea |
Kim, Hyungseok, GFE Manager |
K |
| Samsung Biologics |
James Choi, Executive Vice President |
E |
| 08.26 (Wednesday) |
The Platz Seminar Room |
P-20 |
10:00 - 12:00 |
Seminar on AI-based Drug Development Trends and Future Activation Strategy |
Korea Biomedicine Industry Association (KoBIA) |
|
| 10:00 - 10:30 |
Global AI-Driven New Drug Development Market Trends |
Kyung Hee University |
Hwajin Lee, Assistant Professor |
K |
| 10:30 - 11:00 |
Bottlenecks in AI-Driven New Drug Development — Real-World Case Studies in Molecular Modeling and Talent Development Strategies |
AICADD |
KIM Young-hoon, Founder |
K |
| 11:00 - 11:30 |
New Era: Way to Autonomous Scientific Discovery — Empowered by AI & Robotics Infrastructure |
XtalPi |
Jae-Sung Hwang, Director of Business Development |
K |
| 11:30 - 12:00 |
Building Talent for the AI Drug Discovery Ecosystem |
Korea Health Industry Development Institute |
MINSEOK KIM, PhD, MBA, Principal Researcher |
K |
| P-21 |
13:30 - 14:00 |
Revolutionizing RNAi with SAMiRNA® |
siRNAgen Therapeutics |
Chun Geun Lee, Chief Scientific Officer |
K |
| P-23 |
15:00 - 16:50 |
Integrated Strategies for Biopharmaceutical Development: Raw Materials, Quality Innovation, and Commercialization Success |
Vaccine Center for Assisting Safety & Technology (K-VCAST) |
|
| 15:00 - 15:25 |
Introduction of regulatory trends and test method development for Extractables and Leachables in disposable containers |
KMEDIhub |
Sujin Lee, Lead Researcher |
K |
| 15:25 - 15:50 |
National Cell Bank & Cell Line Characterization, Q-Safety Technical Support System |
K-VCAST |
Joonho Hong, Team Manager |
K |
| 16:10 - 16:30 |
Success Stories of Cell Culture Media and Future Directions for Korea's Bioprocess Raw Materials Industry |
XCELL |
Sean Lee, Director |
K |
| 16:30 - 16:50 |
Status of Domestic Localization of Raw Material Resins and Government Support Directions |
Puriogen |
Ilgwon Kim, Team Manager |
K |
| 08.27 (Thursday) |
The Platz Seminar Room |
P-30 |
10:20 - 12:10 |
DIPS Global Clinical Study |
Korea Institute of Toxicology(KIT) |
|
| 10:00 - 10:40 |
Changes in the Global Clinical Trial Market (Technology, Capital, Regulation) |
TRIALIGN Consulting |
Sally Bang, CEO |
K |
| 10:40 - 11:20 |
Understanding and Utilization of Exploratory Clinical Trials (Phase 0) |
Polara Research |
Daniel Zang, PhD, JD President/Founder |
E |
| 11:30 - 12:10 |
Leveraging RWD for Full Lifecycle Drug Development |
SELTA SQUARE INC. |
Hyejung Lee, Director |
K |